US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Birth Control

2,843.17

-1.9507-0.07%

Number of Gainers:4

Number of Losers:1

Number of Flat:- -

PE:- -

High:2,887.84

Open:2,849.31

Low:2,807.83

Close:2,845.12

Volume:21.25M

Turnover:282.75M

Market Cap:47.47B

Float Cap:44.32B

Loading ...

Press Release: TAPI (Technology & API Services) Names Serge Rogasik CEO to Lead Next Chapter of Growth and Competitiveness

Liquidia ruling has positive read-through for MannKind Tyvaso DPI, says Truist

NYSE Order Imbalance 18799.0 Shares on Buy Side

THOMSON REUTERS

Teva Reports FDA Approval for Degevma

MT Newswires Live

Teva announces FDA approval of Degevma as a biosimilar to Xgeva

Teva Pharmaceutical's Duvakitug Could be Validated by Merck's Tulisokibart Results, Oppenheimer Says

MT Newswires Live

Daré Bioscience Wins New US Patent Covering Topical Lopinavir-Ritonavir Formulation for DARE-HPV Program

Dare Bioscience Announces New U.S. Patent Strengthening Dare-Hpv Program as a Potential First FDA-Approved Pharmacologic Treatment for Hpv Infection

THOMSON REUTERS

NYSE Order Imbalance 23191.0 Shares on Buy Side

THOMSON REUTERS

Teva Releases Q3 2026 Aide Memoire

THOMSON REUTERS

Evofem Contracts Second Manufacturer for Phexxi Contraceptive Gel

Evofem Biosciences Adds Additional Manufacturing Capacity for Phexx® to Support Global Growth Strategy

THOMSON REUTERS

Evofem Biosciences - Additional Manufacturing Source Expected to Reduce Unit Costs by 40% or More

THOMSON REUTERS

Evofem Biosciences - to Submit Snda to FDA for Phexx in Mid-2027

THOMSON REUTERS

Teva Enters Acceleration Phase of Transformation Supported by Multi-Year Launch Cycle, Oppenheimer Says

MT Newswires Live

Top Teva Insider Makes Massive Multi-Million Dollar Stock Move

NYSE Order Imbalance 52798.0 Shares on Buy Side

THOMSON REUTERS

Teva presents new new real-world data on uzedy at Psych Congress

Teva Highlights New Real-World Data Showing Uzedy® (Risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs

THOMSON REUTERS

Teva Pharmaceutical Announces New Senior Notes Offering

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BK4584/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4584","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","market":"US","secType":"PLATE","nameCN":"Birth Control","latestPrice":2843.1685,"timestamp":1790798399999,"preClose":2845.1191,"halted":0,"volume":21249144,"delay":0,"changeRate":-0.000686,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-1.950684,"latestTime":"09-30 16:00:00 EDT","open":2849.3096,"high":2887.8394,"low":2807.832,"amount":282754989.391227,"amplitude":0.028121,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790812800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.01975,"peRate":74.211947,"turnoverRate":0.014797,"increases":4,"decrements":1,"flats":0,"marketCap":47468233586,"floatMarketCap":44323655242},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","high":2887.8394,"amplitude":0.028121,"preClose":2845.1191,"low":2807.832,"pbRate":"6.01975","latestPrice":2843.1685,"volume":21249144,"delay":0,"open":2849.3096,"prevYearClose":2379.9924,"prevWeekClose":2805.3972,"prevMonthClose":2714.4358,"prevQuarterClose":2562.5076,"fiveDayClose":2793.5195,"twentyDayClose":2723.1304,"sixtyDayClose":2616.1365,"secType":"PLATE","market":"US","turnoverRate":0.014797,"peRate":74.211947,"marketCap":47468233586,"floatMarketCap":44323655242,"timestamp":1790798399999,"nameCN":"Birth Control"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4584\",,,,undefined,":{"bkCode":"BK4584","up":4,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4584\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672782213","title":"Press Release: TAPI (Technology & API Services) Names Serge Rogasik CEO to Lead Next Chapter of Growth and Competitiveness","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782213","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782213?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:32","pubTimestamp":1790800320,"startTime":"0","endTime":"0","summary":"TEL AVIV, Israel, Sept. 30, 2026 (GLOBE NEWSWIRE) -- TAPI (Technology & API Services) today announced the appointment of Serge Rogasik as its Chief Executive Officer. Mr. Rogasik will lead a global bu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","LU2324357040.USD","BK4585","BK4596","BK6520","BK4557","OTX.SI","TEVA","BK4559","LU1983299246.USD","BK4007","DBB","BK6100","BK4566","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672789452","title":"Liquidia ruling has positive read-through for MannKind Tyvaso DPI, says Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2672789452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672789452?lang=en_us&edition=fundamental","pubTime":"2026-10-01 01:10","pubTimestamp":1790788218,"startTime":"0","endTime":"0","summary":"Liquidia’s (LQDA) Yutrepia faces a Delaware court finding of infringement of United Therapeutics’ (UTHR) ‘327 patent, pressuring Liquidia shares bu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liquidia-ruling-has-positive-read-through-for-mannkind-tyvaso-dpi-says-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liquidia-ruling-has-positive-read-through-for-mannkind-tyvaso-dpi-says-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU1699723380.USD","USRD","BK4584","UTHR","LQDA","BK4532","BK4007","LU1571399168.USD","MNKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671724230","title":"NYSE Order Imbalance 18799.0 Shares on Buy Side","url":"https://stock-news.laohu8.com/highlight/detail?id=2671724230","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671724230?lang=en_us&edition=fundamental","pubTime":"2026-09-30 03:50","pubTimestamp":1790711402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nAQN2MLD8J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4566","BK4584","BK4557","LU2324357040.USD","BK4585","TEVA","BK4559","BK4596","LU1983299246.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671250803","title":"Teva Reports FDA Approval for Degevma","url":"https://stock-news.laohu8.com/highlight/detail?id=2671250803","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671250803?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:25","pubTimestamp":1790627151,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries  said late Monday the US Food and Drug Administration has approved Degevma as a biosimilar to Xgeva.Degevma is indicated for the prevention of bone complications in adults with advanced cancer that has spread to the bone, it said.The drug is also indicated for the treatment of adults and skeletally mature adolescents with giant cell tumor of bone and for the treatment of hypercalcemia of malignancy, Teva said.Teva said it expects to launch Degevma and Ponlimsi in the US in the coming months. Ponlimsi was approved in March.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","TEVA","BK4585","LU1983299246.USD","BK4588","BK4584","LABU","BK4557","LU2324357040.USD","BK4596","BK4559","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671125702","title":"Teva announces FDA approval of Degevma as a biosimilar to Xgeva","url":"https://stock-news.laohu8.com/highlight/detail?id=2671125702","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671125702?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:05","pubTimestamp":1790625914,"startTime":"0","endTime":"0","summary":"Teva (TEVA) Pharmaceutical Industries announced that the FDA has approved Degevma as a biosimilar to Xgeva. Degevma is indicated for the prevention...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-of-degevma-as-a-biosimilar-to-xgeva-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-of-degevma-as-a-biosimilar-to-xgeva-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","BK4559","PSCH","BK4584","FRTY","BK4557","IDNA","MRNX","BK4566","BMED","LU2324357040.USD","PINK","IYH","XLVX","TEVA","BK4588","LABU","BBP","TECB","GNMX","BK4007","TBXU","SYNB","NVIB","BK4596","IBB","LFSC","IEIH","LU1983299246.USD","BK4585","MRNY","RSPH","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670525939","title":"Teva Pharmaceutical's Duvakitug Could be Validated by Merck's Tulisokibart Results, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2670525939","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670525939?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:49","pubTimestamp":1790610591,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical's (TEVA) Duvakitug inflammatory bowel disease drug could be validated by Merck's (MRK) upcoming Tulisokibart results, Oppenheimer said in a Friday note.Analysts said that the best ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FHLC","LU2468319806.SGD","LU1929549753.HKD","BK4559","IXJ","LU1585245621.USD","LU1069347547.HKD","LU0320765646.SGD","LU1057294990.SGD","LU0289961442.SGD","SG9999014542.SGD","SG9999013999.USD","LU1699723380.USD","BK4550","LU0070302665.USD","LU2112291526.USD","LU0980610538.SGD","LU1037948897.HKD","LU0106261372.USD","LU2125909593.SGD","LU1917777945.USD","LU2106854487.HKD","LU1093756168.USD","LU1934455863.HKD","LU0266013472.USD","LU0058720904.USD","BMED","IE0009355771.USD","LU1066051498.USD","LU2433249047.HKD","HRTS","LU2125154778.USD","LU1934455277.USD","IE00BBT3K403.USD","LU0098860793.USD","IE000M9KFDE8.USD","LU1923622614.USD","LU0289739699.SGD","LU1934455194.USD","SG9999001176.USD","XLV","SG9999001176.SGD","PPH","LU1035773651.USD","LU0289739343.SGD","LU0162691827.USD","LU0238689110.USD","LU2125154935.USD","SG9999002232.USD","BK4557","LU1201861249.SGD","MRK","LU0942090050.USD","LU1116320901.HKD","BK4007","IE00BN8TJ469.HKD","IE00B4R5TH58.HKD","LU0965509101.SGD","IHE","LU2023250504.SGD","SG9999015341.SGD","IE00BJJMRZ35.SGD","LU0648001328.SGD","LU0859254822.USD","LU2357627491.SGD","RXL","LU0965509010.AUD","LU0069063385.USD","LU1974910355.USD","SG9999002224.SGD","TEVA","LU0057025933.USD","BK4533","GDOC","LU1430594728.SGD","LU0985320562.USD","LU0861579265.USD","BK4566","IE00BLSP4239.USD","IE00BLSP4452.SGD","IE00BFTCPJ56.SGD","LU0124676726.USD","LU0265550359.USD","LU1291159041.SGD","LU1023059063.AUD","LU1941712264.USD","SG9999014559.SGD","LU1032466523.USD","LU1989771016.USD","LU2361044949.HKD","LU0965509283.SGD","LU2361045086.USD","LU2361044865.SGD","LU0689626769.HKD","LU1983299246.USD","LU0203347892.USD","LU0868494708.USD","LU0211331839.USD","IYH","LU0122379950.USD","LU2324357040.USD","LU1116320737.USD","LU1066051811.HKD","LU0234572021.USD","IE00BJT1NW94.SGD","SGXZ57979304.SGD","LU0203345920.USD","LU1066053197.SGD","LU1162221912.USD","LU1061106388.HKD","BK4588","BK4584","SG9999015358.SGD","SG9999001440.SGD","LU0823416689.USD","TRUH","LU2360032135.SGD","LU0432979614.USD","SG9999014575.USD","LU0208291251.USD","LU0265550946.USD","LU1571399168.USD","BK4585","JDOC","SG9999014567.USD","BK4534","LU1989772923.USD","LU1941712348.USD","FTXH","VHT","IE00B1BXHZ80.USD","LU0477156953.USD","LU0130517989.USD","LU1989772840.SGD","LU2125909247.SGD","LU2461242641.AUD","LU0006306889.USD","LU0130102774.USD","IE0002141913.USD","LU0320765489.SGD","LU0868494617.USD","LU0472753341.HKD","IE00B2B36J28.USD","LU1093756325.SGD","LU1037948541.HKD","LU0511384066.AUD","LU2089984988.USD","IE00BSNM7G36.USD","LU2491050071.SGD","PAWZ","LU2491049909.HKD","LU0072461881.USD","BK4516","LU2491050154.USD","LU2023250843.SGD","LU1066051225.USD","LU0965508806.USD","BK4596"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670523272","title":"Daré Bioscience Wins New US Patent Covering Topical Lopinavir-Ritonavir Formulation for DARE-HPV Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2670523272","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670523272?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:20","pubTimestamp":1790598019,"startTime":"0","endTime":"0","summary":"Daré Bioscience wins new US patent covering topical lopinavir-ritonavir formulation for DARE-HPV programDaré Bioscience secured U.S. Patent No. 12,678,439 covering topical lopinavir-ritonavir formulat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL3dPK6f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","SG9999014005.SGD","NDAQ","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","IE00BKPKM429.USD","BK4584","IE00B64PRP62.GBP","BCDF","LU2210150020.SGD","BK4007","BK4585","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","SG9999014039.USD","BK4588","IE00BN0W2W23.USD","SG9999014021.USD","LU2210149790.SGD","LU2095319765.USD","DARE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670232711","title":"Dare Bioscience Announces New U.S. Patent Strengthening Dare-Hpv Program as a Potential First FDA-Approved Pharmacologic Treatment for Hpv Infection","url":"https://stock-news.laohu8.com/highlight/detail?id=2670232711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670232711?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:20","pubTimestamp":1790598000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUA39SRQF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DARE","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670490255","title":"NYSE Order Imbalance 23191.0 Shares on Buy Side","url":"https://stock-news.laohu8.com/highlight/detail?id=2670490255","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670490255?lang=en_us&edition=fundamental","pubTime":"2026-09-25 03:50","pubTimestamp":1790279400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nAQN2MKNHV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","BK4588","BK4557","BK4584","LU1983299246.USD","BK4559","LU2324357040.USD","TEVA","BK4585","BK4007","BK4596"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669095436","title":"Teva Releases Q3 2026 Aide Memoire","url":"https://stock-news.laohu8.com/highlight/detail?id=2669095436","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669095436?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:45","pubTimestamp":1790196300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUABKND6J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","LU1983299246.USD","BK4559","BK4585","BK4566","BK4584","BK4007","LU2324357040.USD","BK4557","TEVA","BK4596"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436369","title":"Evofem Contracts Second Manufacturer for Phexxi Contraceptive Gel","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436369","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436369?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:07","pubTimestamp":1790194021,"startTime":"0","endTime":"0","summary":"Evofem contracts second manufacturer for Phexxi contraceptive gelEvofem Biosciences contracted a second pharmaceutical manufacturer to produce its PHEXX prescription contraceptive vaginal gel, expandi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL1D159v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVFM","BK4584","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436895","title":"Evofem Biosciences Adds Additional Manufacturing Capacity for Phexx® to Support Global Growth Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436895","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436895?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:05","pubTimestamp":1790193946,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0YB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4007","EVFM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436800","title":"Evofem Biosciences - Additional Manufacturing Source Expected to Reduce Unit Costs by 40% or More","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436800","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436800?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:05","pubTimestamp":1790193946,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0YB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","EVFM","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669243680","title":"Evofem Biosciences - to Submit Snda to FDA for Phexx in Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2669243680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669243680?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:05","pubTimestamp":1790193946,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0YB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4584","EVFM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669480359","title":"Teva Enters Acceleration Phase of Transformation Supported by Multi-Year Launch Cycle, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669480359","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669480359?lang=en_us&edition=fundamental","pubTime":"2026-09-24 00:13","pubTimestamp":1790180005,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical (TEVA) is entering a strong growth phase despite near-term concerns around Austedo and gRevlimid, Oppenheimer said in a note Wednesday.The analysts said the company is entering the","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU1983299246.USD","BK4557","BK4559","BK4566","LU2324357040.USD","BK4007","TEVA","BK4596","BK4585","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669792051","title":"Top Teva Insider Makes Massive Multi-Million Dollar Stock Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2669792051","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669792051?lang=en_us&edition=fundamental","pubTime":"2026-09-23 10:03","pubTimestamp":1790128985,"startTime":"0","endTime":"0","summary":"New insider activity at Teva Pharmaceutical ( ($TEVA) ) has taken place on September 22, 2026. Teva Pharmaceutical has seen a notable insider move ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-teva-insider-makes-massive-multi-million-dollar-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-teva-insider-makes-massive-multi-million-dollar-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4596","LU2324357040.USD","BK4557","LU1983299246.USD","TEVA","BK4585","BK4007","BK4588","BK4566","BK4584","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669327198","title":"NYSE Order Imbalance 52798.0 Shares on Buy Side","url":"https://stock-news.laohu8.com/highlight/detail?id=2669327198","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669327198?lang=en_us&edition=fundamental","pubTime":"2026-09-22 03:50","pubTimestamp":1790020203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nAQN2MK64P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4559","TEVA","BK4584","BK4588","BK4557","BK4007","LU2324357040.USD","BK4596","BK4566","LU1983299246.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668758919","title":"Teva presents new new real-world data on uzedy at Psych Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2668758919","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668758919?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:50","pubTimestamp":1789764616,"startTime":"0","endTime":"0","summary":"Teva (TEVA) Pharmaceuticals announced new real-world data evaluating treatment continuity, healthcare resource utilization and clinical outcomes am...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-presents-new-new-real-world-data-on-uzedy-at-psych-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-presents-new-new-real-world-data-on-uzedy-at-psych-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","BK4588","NOBL","BK4557","BK4559","BK4585","BK4584","TEVA","VHT","LU1983299246.USD","BK4596","BK4550","CGCV","BK4007","IXJ","TCAF","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668987973","title":"Teva Highlights New Real-World Data Showing Uzedy® (Risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2668987973","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668987973?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:31","pubTimestamp":1789763460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nTUA9WVSCG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","BK4566","BK4559","BK4585","BK4596","LU1983299246.USD","BK4007","BK4584","BK4588","TEVA","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668702935","title":"Teva Pharmaceutical Announces New Senior Notes Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2668702935","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668702935?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:49","pubTimestamp":1789591748,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical ( ($TEVA) ) has issued an update. On September 16, 2026, Teva’s Dutch finance units issued €1.5 billion of senior euro notes an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/teva-pharmaceutical-announces-new-senior-notes-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/teva-pharmaceutical-announces-new-senior-notes-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1983299246.USD","LU2324357040.USD","BK4585","BK4588","BK4596","BK4559","BK4007","BK4566","TEVA","BK4557","BK4584"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}